跳至主要内容
临床试验/NCT00593762
NCT00593762暂停不适用

Investigation of Laboratory Resistance to Aspirin and Clopidogrel and Its Clinical Relevance in Patients With Peripheral Arterial Occlusive Disease Requiring Interventional Procedures

Johann Wolfgang Goethe University Hospital1 个研究点 分布在 1 个国家目标入组 200 人开始时间: 2005年5月最近更新:
适应症

试验速览

阶段
不适用
状态
暂停
发起方
入组人数
200
试验地点
1
主要终点
Need for peripheral arterial revascularisation

研究概览

简要总结

The purpose of the study is to determine the response to aspirin (ASA) and Clopidogrel in patients with peripheral arterial occlusive disease (PAOD) requiring interventional procedures and to investigate if patients with "resistance" to ASA or Clopidogrel have an unfavourable outcome during long-term follow-up

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 85 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • PAOD patients
  • Age 18-85 years
  • Need for a catheter interventional procedure
  • Antithrombotic therapy with aspirin or clopidogrel

排除标准

  • Comedication additionally compromising platelet function
  • Known bleeding disorder
  • Life expectancy < 6 months

结局指标

主要结局

Need for peripheral arterial revascularisation

时间窗: 1, 6, 12 and 24 months

次要结局

  • Cardiovascular events (death, myocardial infarction, stroke, ACS, PCI)(1, 6, 12 and 24 months)

研究者

发起方
Johann Wolfgang Goethe University Hospital
申办方类型
Other

研究点 (1)

Loading locations...

相似试验

ASA- and Clopidogrel-Responsiveness in Patients With... | 临床试验